Timothy E. Morris
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Timothy E. Morris
Timothy E. Morris is recorded as Board Member at Aquestive Therapeutics, Inc. (AQST). Aquestive Therapeutics, Inc. reported in an 8-K filed November 7, 2024 that Timothy E. Morris was appointed member of the Compensation Committee, effective November 4, 2024. Aquestive Therapeutics, Inc. reported in an 8-K filed August 10, 2022 that Timothy E. Morris was appointed Board, effective August 5, 2022.
“Effective November 4, 2024, John S. Cochran, a member of the Company's Board of Directors and Compensation Committee, will serve as the Chair of the Compensation Committee and Timothy E. Morris, a member of the Board of Directors and Chair of the Audit Committee of the Board of Directors will be appointed to the Compensation Committee.”
“On August 10, 2022, the Company announced the appointment of Timothy E. Morris to the Company's Board, effective August 5, 2022.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-11-04–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Aquestive Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Daniel Barber CEO, Board Member
- Gregory B. Brown Chairman
- John S. Cochran Chairman
- A. Ernest Toth CFO
- A. Ernest Toth, Jr. CFO
- Cassie Jung COO
- Thomas A. Zalewski General Counsel
- Abigail L. Jenkins Board Member
- Julie Krop Board Member
- Marco Taglietti Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.